These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 4623326)
1. [Role of glibenclamide in the therapy of diabetes]. Parodi FA Minerva Med; 1972 Apr; 63(28):1629-32. PubMed ID: 4623326 [No Abstract] [Full Text] [Related]
2. Progress in oral therapy of diabetes mellitus with sulphonylureas of the second generation. Raptis S; Pfeiffer EF Acta Diabetol Lat; 1972; 9(6):865-99. PubMed ID: 4197419 [No Abstract] [Full Text] [Related]
3. [Glibenclamide and diabetes mellitus. 1. Year's clinical experience]. Contreras AR; Gabrielli S; Baigorria L Prensa Med Argent; 1972 May; 59(15):581-3. PubMed ID: 4626172 [No Abstract] [Full Text] [Related]
4. Treatment of chemical diabetes mellitus with sulfonylurea compounds. Fajans SS Metabolism; 1973 Feb; 22(2):373-6. PubMed ID: 4687964 [No Abstract] [Full Text] [Related]
5. Oral management of uncomplicated maturity onset diabetes. Mashaly M; el-Ebrashy N; Higazi AM; Einen MA; Aziz MT J Egypt Med Assoc; 1974; 57(7-8):288-97. PubMed ID: 4217809 [No Abstract] [Full Text] [Related]
7. The clinical evaluation of an oral antidiabetic drug. Müller R Aust N Z J Med; 1971 Aug; 1():Suppl 2:39-46. PubMed ID: 5005130 [No Abstract] [Full Text] [Related]
8. A clinical pharmacologic comparison of glyhexamide, tolbutamide and chlorpropamide in the treatment of stable diabetes. Grinnell EH; Skillman TG; Brooks AM Am J Med Sci; 1967 Mar; 253(3):312-20. PubMed ID: 5336725 [No Abstract] [Full Text] [Related]
9. [Clinical testing of a sulphonylurea derivative, glibornuride]. Zöllner N; Dörfler H; Wolfram G Dtsch Med Wochenschr; 1972 Jul; 97(29):1083-8. PubMed ID: 4625427 [No Abstract] [Full Text] [Related]
10. [Clinical evaluation of a new sulfonylurea (Ro-6-4563) in the treatment of stable diabetes in adults]. Artega A; Soto S; Eyzaguirre J; Foradori A; Alliende ME Rev Med Chil; 1972 Jun; 100(6):635-8. PubMed ID: 5083349 [No Abstract] [Full Text] [Related]
11. [New aspects of therapy with oral antidiabetic agents]. Haslbeck M Wien Med Wochenschr; 1979 Dec; 199(24):689-95. PubMed ID: 161940 [No Abstract] [Full Text] [Related]
12. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures]. Tattersall RB Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219 [No Abstract] [Full Text] [Related]
13. [Glibenclamide, a new oral antidiabetic]. Edlén A Lakartidningen; 1972 Jan; 69(4):342-3. PubMed ID: 4622487 [No Abstract] [Full Text] [Related]
14. [Effect of long-term therapy with sulfanylurea preparations on the relation of insulin secretion and the insulin-binding capacity of its receptors]. Balabolkin MI; Nedosugova LV Ter Arkh; 1988; 60(12):91-6. PubMed ID: 3150136 [No Abstract] [Full Text] [Related]
15. Treatment with glibenclamide in maturity-onset diabetes mellitus. Persson I; Madsen SN Geriatrics; 1971 May; 26(5):182-95. PubMed ID: 5004113 [No Abstract] [Full Text] [Related]
16. An open comparative study of the efficacy and tolerance of a new antidiabetic agent: glipizide. De Leeuw I; De Baere H; Decraene P; Lemmens P; Verhaegen H Diabetologia; 1973 Sep; ():364-6. PubMed ID: 4204093 [No Abstract] [Full Text] [Related]
17. Controlled extension of oral antidiabetic therapy on former insulin dependent diabetics by means of the combined i.v. glibenclamide-glucose-response-test. Pfeiffer EF; Raptis S Diabetologia; 1972 Feb; 8(1):41-7. PubMed ID: 4623790 [No Abstract] [Full Text] [Related]
18. Clinical experiences in oral antidiabetic therapy with sulphonylureas and biguanides. Schöffling K Aust N Z J Med; 1971 Aug; 1():Suppl 2:47-56. PubMed ID: 5005131 [No Abstract] [Full Text] [Related]
19. [Therapy of diabetes in adults using Glibornurid. Results and clinical studies]. Schöffling K; Mehnert H; Ewald W; Haupt E; Wicklmayr M; Beyer J; Nemeth N Dtsch Med Wochenschr; 1973 May; 98(18):915-9. PubMed ID: 4633717 [No Abstract] [Full Text] [Related]
20. [Preliminary clinical experiences and problems of long-term therapy of diabetes mellitus using 2nd generation sulfonylurea derivatives (glibenclamide)]. Schilling I; Bruns W; Haller H; Mehnert E; Mohnike A; Jutzi E; Schliack V; Schulze J Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:149-5. PubMed ID: 4200337 [No Abstract] [Full Text] [Related] [Next] [New Search]